Works by Fukunishi, Shinya


Results: 107
    1

    Clinical Impact of Serum CRP Levels on Advanced HCC Treated With Durvalumab and Tremelimumab: A Multicentre Study.

    Published in:
    Liver International, 2025, v. 45, n. 7, p. 1, doi. 10.1111/liv.70192
    By:
    • Hatanaka, Takeshi;
    • Yata, Yutaka;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Kakizaki, Satoru;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Toyoda, Hidenori;
    • Koshiyama, Yuichi;
    • Ogawa, Chikara;
    • Nishikawa, Hiroki;
    • Nishimura, Takashi
    Publication type:
    Article
    2

    Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.

    Published in:
    Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    3

    Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.

    Published in:
    Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028
    By:
    • Ohama, Hideko;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    4

    Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.

    Published in:
    Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Hirooka, Masashi;
    • Takaguchi, Koichi;
    • Atsukawa, Masanori;
    • Fukunishi, Shinya;
    • Itobayashi, Ei;
    • Tsuji, Kunihiko;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Ishikawa, Toru;
    • Yasuda, Satoshi;
    • Ogawa, Chikara;
    • Toyoda, Hidenori;
    • Hatanaka, Takeshi;
    • Nishimura, Takashi;
    • Kakizaki, Satoru
    Publication type:
    Article
    5

    Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    6

    Impact of Early Lenvatinib Administration on Survival in Patients with Intermediate-Stage Hepatocellular Carcinoma: A Multicenter, Inverse Probability Weighting Analysis.

    Published in:
    Oncology, 2021, v. 99, n. 8, p. 518, doi. 10.1159/000515896
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Michitaka, Kojiro;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Fukunishi, Shinya;
    • Ohama, Hideko;
    • Kawata, Kazuhito
    Publication type:
    Article
    7

    Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.

    Published in:
    Oncology, 2020, v. 98, n. 5, p. 295, doi. 10.1159/000506293
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Toyoda, Hidenori;
    • Ohama, Hideko;
    • Tsutsui, Akemi;
    • Itokawa, Norio
    Publication type:
    Article
    8

    Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma.

    Published in:
    Liver Cancer International, 2023, v. 4, n. 3, p. 101, doi. 10.1002/lci2.74
    By:
    • Nouso, Kazuhiro;
    • Shiota, Shohei;
    • Fujita, Rio;
    • Wakuta, Akiko;
    • Kariyama, Kazuya;
    • Hiraoka, Atsushi;
    • Atsukawa, Masanori;
    • Tani, Joji;
    • Tada, Toshifumi;
    • Matsuo, Yu;
    • Nakamura, Shinichiro;
    • Tajiri, Kazuto;
    • Kaibori, Masaki;
    • Hirooka, Masashi;
    • Itobayashi, Ei;
    • Kakizaki, Satoru;
    • Naganuma, Atsushi;
    • Ishikawa, Toru;
    • Hatanaka, Takeshi;
    • Fukunishi, Shinya
    Publication type:
    Article
    9

    Grip Strength in Patients with Gastrointestinal Diseases.

    Published in:
    Journal of Clinical Medicine, 2022, v. 11, n. 8, p. 2079, doi. 10.3390/jcm11082079
    By:
    • Asaishi, Ken;
    • Matsui, Masahiro;
    • Nishikawa, Hiroki;
    • Goto, Masahiro;
    • Asai, Akira;
    • Ushiro, Kosuke;
    • Ogura, Takeshi;
    • Takeuchi, Toshihisa;
    • Nakamura, Shiro;
    • Kakimoto, Kazuki;
    • Miyazaki, Takako;
    • Fukunishi, Shinya;
    • Ohama, Hideko;
    • Yokohama, Keisuke;
    • Yasuoka, Hidetaka;
    • Higuchi, Kazuhide
    Publication type:
    Article
    10
    11
    12
    13

    Comparison of SARC-F Score among Gastrointestinal Diseases.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4099, doi. 10.3390/jcm10184099
    By:
    • Ushiro, Kosuke;
    • Nishikawa, Hiroki;
    • Matsui, Masahiro;
    • Ogura, Takeshi;
    • Takeuchi, Toshihisa;
    • Goto, Masahiro;
    • Nakamura, Shiro;
    • Kakimoto, Kazuki;
    • Miyazaki, Takako;
    • Fukunishi, Shinya;
    • Asai, Akira;
    • Ohama, Hideko;
    • Yokohama, Keisuke;
    • Yasuoka, Hidetaka;
    • Higuchi, Kazuhide
    Publication type:
    Article
    14
    15

    Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.

    Published in:
    Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    16

    What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
    By:
    • Atsushi Hiraoka;
    • Takashi Kumada;
    • Toshifumi Tada;
    • Kazuya Kariyama;
    • Joji Tani;
    • Shinya Fukunishi;
    • Masanori Atsukawa;
    • Masashi Hirooka;
    • Kunihiko Tsuji;
    • Toru Ishikawa;
    • Koichi Takaguchi;
    • Ei Itobayashi;
    • Kazuto Tajiri;
    • Noritomo Shimada;
    • Hiroshi Shibata;
    • Hironori Ochi;
    • Kazuhito Kawata;
    • Satoshi Yasuda;
    • Hidenori Toyoda;
    • Hideko Ohama
    Publication type:
    Article
    17

    Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

    Published in:
    Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Yokohama, Keisuke;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya
    Publication type:
    Article
    18

    Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
    By:
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishikawa, Hiroki;
    • Nishimura, Takashi;
    • Kawata, Kazuhito;
    • Kosaka, Hisashi
    Publication type:
    Article
    19

    Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Nishikawa, Hiroki;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Koshiyama, Yuichi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Kawata, Kazuhito
    Publication type:
    Article
    20

    Sarcopenia, frailty and type 2 diabetes mellitus.

    Published in:
    Molecular Medicine Reports, 2021, v. 24, n. 6, p. N.PAG, doi. 10.3892/mmr.2021.12494
    By:
    • Nishikawa, Hiroki;
    • Fukunishi, Shinya;
    • Asai, Akira;
    • Yokohama, Keisuke;
    • Ohama, Hideko;
    • Nishiguchi, Shuhei;
    • Higuchi, Kazuhide
    Publication type:
    Article
    21
    22

    Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-78539-4
    By:
    • Ohama, Hideko;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    23

    The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2019, v. 49, n. 9, p. 1230, doi. 10.1111/apt.15218
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Toyoda, Hidenori;
    • Takaguchi, Koichi;
    • Nakamuta, Makoto;
    • Watanabe, Tsunamasa;
    • Michitaka, Kojiro;
    • Ikegami, Tadashi;
    • Nozaki, Akito;
    • Uojima, Haruki;
    • Fukunishi, Shinya;
    • Genda, Takuya;
    • Abe, Hiroshi;
    • Hotta, Naoki;
    • Tsuji, Kunihiko;
    • Ogawa, Chikara;
    • Tachi, Yoshihiko;
    • Shima, Toshihide;
    • Shimada, Noritomo;
    • Kondo, Chisa
    Publication type:
    Article
    24
    25
    26

    Sarcopenia and Frailty in Liver Cirrhosis.

    Published in:
    Life (2075-1729), 2021, v. 11, n. 5, p. 399, doi. 10.3390/life11050399
    By:
    • Nishikawa, Hiroki;
    • Fukunishi, Shinya;
    • Asai, Akira;
    • Nishiguchi, Shuhei;
    • Higuchi, Kazuhide;
    • Jun, Dae Won;
    • Saeed, Waqar K.;
    • Miraglia, Roberto
    Publication type:
    Article
    27
    28
    29

    Cancer Cachexia: Its Mechanism and Clinical Significance.

    Published in:
    International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 8491, doi. 10.3390/ijms22168491
    By:
    • Nishikawa, Hiroki;
    • Goto, Masahiro;
    • Fukunishi, Shinya;
    • Asai, Akira;
    • Nishiguchi, Shuhei;
    • Higuchi, Kazuhide
    Publication type:
    Article
    30

    Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?

    Published in:
    International Journal of Molecular Sciences, 2020, v. 21, n. 14, p. 4939, doi. 10.3390/ijms21144939
    By:
    • Sumida, Yoshio;
    • Yoneda, Masashi;
    • Toyoda, Hidenori;
    • Yasuda, Satoshi;
    • Tada, Toshifumi;
    • Hayashi, Hideki;
    • Nishigaki, Yoichi;
    • Suzuki, Yusuke;
    • Naiki, Takafumi;
    • Morishita, Asahiro;
    • Tobita, Hiroshi;
    • Sato, Shuichi;
    • Kawabe, Naoto;
    • Fukunishi, Shinya;
    • Ikegami, Tadashi;
    • Kessoku, Takaomi;
    • Ogawa, Yuji;
    • Honda, Yasushi;
    • Nakahara, Takashi;
    • Munekage, Kensuke
    Publication type:
    Article
    31

    Therapeutic efficacy of ramucirumab after lenvatinib for post-progression treatment of unresectable hepatocellular carcinoma.

    Published in:
    Gastroenterology Report, 2021, v. 9, n. 2, p. 133, doi. 10.1093/gastro/goaa042
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Tada, Toshifumi;
    • Ogawa, Chikara;
    • Tani, Joji;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Toyoda, Hidenori;
    • Ohama, Hideko
    Publication type:
    Article
    32

    Survival Outcomes Associated With Radiological Progressive Disease Subtypes in Patients With Atezolizumab and Bevacizumab–Treated HCC.

    Published in:
    Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 4, p. 949, doi. 10.1111/jgh.16884
    By:
    • Matono, Tomomitsu;
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Nishikawa, Hiroki;
    • Tanaka, Kazunari;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Koshiyama, Yuichi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Hatanaka, Takeshi
    Publication type:
    Article
    33

    Reliable Performance of mALBI Grade‐Based Risk Models for Predicting the Prognosis of Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab as First‐Line Treatment: Comparative Analysis of 13 Risk Models.

    Published in:
    Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 4, p. 930, doi. 10.1111/jgh.16871
    By:
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru;
    • Hiraoka, Atsushi;
    • Tada, Toshifumi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishikawa, Hiroki;
    • Nishimura, Takashi;
    • Kawata, Kazuhito;
    • Kosaka, Hisashi
    Publication type:
    Article
    34

    Impact of first‐line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 8, p. 1389, doi. 10.1111/jgh.16225
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Hirooka, Masashi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Atsukawa, Masanori;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Fukunishi, Shinya;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Tajiri, Kazuto;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ogawa, Chikara;
    • Nishimura, Takashi;
    • Hatanaka, Takeshi;
    • Kakizaki, Satoru
    Publication type:
    Article
    35

    Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.

    Published in:
    Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1812, doi. 10.1111/jgh.15336
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Kariyama, Kazuya;
    • Tada, Toshifumi;
    • Tani, Joji;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Ohama, Hideko
    Publication type:
    Article
    36

    Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real‐world setting: A large, multicenter study from Japan.

    Published in:
    Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1420, doi. 10.1111/jgh.14982
    By:
    • Toyoda, Hidenori;
    • Atsukawa, Masanori;
    • Watanabe, Tsunamasa;
    • Nakamuta, Makoto;
    • Uojima, Haruki;
    • Nozaki, Akito;
    • Takaguchi, Koichi;
    • Fujioka, Shinichi;
    • Iio, Etsuko;
    • Shima, Toshihide;
    • Akahane, Takehiro;
    • Fukunishi, Shinya;
    • Asano, Toru;
    • Michitaka, Kojiro;
    • Tsuji, Kunihiko;
    • Abe, Hiroshi;
    • Mikami, Shigeru;
    • Okubo, Hironao;
    • Okubo, Tomomi;
    • Shimada, Noritomo
    Publication type:
    Article
    37

    Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.

    Published in:
    Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 7, p. 1229, doi. 10.1111/jgh.14965
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Takaguchi, Koichi;
    • Toyoda, Hidenori;
    • Iwasa, Motoh;
    • Ikegami, Tadashi;
    • Chuma, Makoto;
    • Nozaki, Akito;
    • Uojima, Haruki;
    • Hiraoka, Atsushi;
    • Fukunishi, Shinya;
    • Yokohama, Keisuke;
    • Tada, Toshifumi;
    • Kato, Keizo;
    • Abe, Hiroshi;
    • Tani, Joji;
    • Okubo, Hironao;
    • Watanabe, Tsunamasa;
    • Hattori, Nobuhiro;
    • Tsutsui, Akemi
    Publication type:
    Article
    38

    Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.

    Published in:
    Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 5, p. 855, doi. 10.1111/jgh.14874
    By:
    • Toyoda, Hidenori;
    • Atsukawa, Masanori;
    • Watanabe, Tsunamasa;
    • Nakamuta, Makoto;
    • Uojima, Haruki;
    • Nozaki, Akito;
    • Takaguchi, Koichi;
    • Fujioka, Shinichi;
    • Iio, Etsuko;
    • Shima, Toshihide;
    • Akahane, Takehiro;
    • Fukunishi, Shinya;
    • Asano, Toru;
    • Michitaka, Kojiro;
    • Tsuji, Kunihiko;
    • Abe, Hiroshi;
    • Mikami, Shigeru;
    • Okubo, Hironao;
    • Okubo, Tomomi;
    • Shimada, Noritomo
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45

    Laparoscopic liver resection for patients with cardiac disease.

    Published in:
    Contemporary Oncology / Współczesna Onkologia, 2019, v. 23, n. 1, p. 37, doi. 10.5114/wo.2019.84109
    By:
    • Yoshihiro Inoue;
    • Syuji Kagota;
    • Yusuke Tsuchimoto;
    • Takeshi Ogura;
    • Akira Asai;
    • Shinya Fukunishi;
    • Kazuhide Higuchi;
    • Kazuhisa Uchiyama
    Publication type:
    Article
    46

    The utility of the subcuticular suture in hepatic resection.

    Published in:
    Contemporary Oncology / Współczesna Onkologia, 2018, v. 22, n. 3, p. 184, doi. 10.5114/wo.2018.78940
    By:
    • Yoshihiro Inoue;
    • Kensuke Fujii;
    • Masatsugu Ishii;
    • Syuji Kagota;
    • Hiroki Hamamoto;
    • Wataru Osumi;
    • Yusuke Tsuchimoto;
    • Shinsuke Masubuchi;
    • Masashi Yamamoto;
    • Akira Asai;
    • Koji Komeda;
    • Shinya Fukunishi;
    • Fumitoshi Hirokawa;
    • Kazuhide Higuchi;
    • Kazuhisa Uchiyama
    Publication type:
    Article
    47
    48
    49

    Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study.

    Published in:
    Infectious Diseases & Therapy, 2020, v. 9, n. 4, p. 851, doi. 10.1007/s40121-020-00329-y
    By:
    • Atsukawa, Masanori;
    • Tsubota, Akihito;
    • Kondo, Chisa;
    • Toyoda, Hidenori;
    • Nakamuta, Makoto;
    • Takaguchi, Koichi;
    • Watanabe, Tsunamasa;
    • Hiraoka, Atsushi;
    • Uojima, Haruki;
    • Ishikawa, Toru;
    • Iwasa, Motoh;
    • Tada, Toshifumi;
    • Nozaki, Akito;
    • Chuma, Makoto;
    • Fukunishi, Shinya;
    • Asai, Akira;
    • Asano, Toru;
    • Ogawa, Chikara;
    • Abe, Hiroshi;
    • Hotta, Naoki
    Publication type:
    Article
    50

    Comparison of resection site of standardized laparoscopic hepatic tumor resection.

    Published in:
    Videosurgery & Other Miniinvasive Techniques / Wideochirurgia i Inne Techniki Mało Inwazyjne, 2018, v. 13, n. 3, p. 333, doi. 10.5114/wiitm.2018.75866
    By:
    • Yoshihiro Inoue;
    • Masatsugu Ishii;
    • Yusuke Tsuchimoto;
    • Shinsuke Masubuchi;
    • Masashi Yamamoto;
    • Akira Asai;
    • Shinya Fukunishi;
    • Fumitoshi Hirokawa;
    • Kazuhide Higuchi;
    • Kazuhisa Uchiyama
    Publication type:
    Article